Lösungen & Regulierung:
Clearing services - Market solutions
CACEIS offers a complete clearing service covering listed and OTC derivatives markets. This wide-ranging multi-asset solution is fully-integrated into the CACEIS Prime Custody package, one of the key elements of our Execution-to-Custody model
Regulatory Reporting services - Asset administration
EMIR (European Market Infrastructure Regulation)
OTC Derivatives Services - Middle Office solutions
News, Pressemitteilungen, Events & Interviews:
04/14/2021 - CACEIS Regulatory Watch Newsletter
03/17/2021 - CACEIS Regulatory Watch Newsletter
EMIR: possible solutions for difficulties mandatory clearing
02/11/2021 - Recital 26 of EMIR expressly acknowledged that to avoid the likely negative impact of such a requirement on the retirement income of future pensioners, the clearing obligation should not apply to pension schemes until a suitable technical solution for the posting of non-cash collateral as variation margin had been developed by Central Counterparties to address pension funds' lack of cash for use as collateral.
02/10/2021 - CACEIS Regulatory Watch Newsletter
EMIR: mandatory clearing poses difficulties for PSA
02/05/2021 - On 17th December 2020, the European Securities and Markets Authority (ESMA) issued its second report on the clearing solutions for Pension Scheme Arrangements under EMIR.
01/18/2021 - CACEIS Regulatory Watch Newsletter
EMIR clearing obligation: the deadline is approaching
11/19/2018 - Since June 2016, mandatory clearing of OTC derivatives imposed by EMIR has gradually increased for a large proportion of financial counterparties. It will become a reality for Class 4 counterparties on 21st December 2018 and Class 3 counterparties on 21st June 2019, two years after the date initially set.
EMIR: Exchange of collateral for uncleared OTC derivatives
05/25/2017 - On 15th December 2016, the European Commission published the delegated regulation of 4th October 2016 on over-the-counter derivatives and established a requirement to exchange variation and/or initial margins on OTC derivatives not cleared by a central counterparty.